Skip to content

Jeffrey T. Klenz, M.D.

NPI 1376527630ActiveIndividual· Internal Medicine, Pulmonary Disease· Burlington, MA

Internal Medicine, Pulmonary Disease (M.D.) in Burlington, Massachusetts, licensed in MA, with an NPI issued in December 2005. Their prescriptions cost Medicare Part D more than their services did: $2,295,722 for 4,296 claims, against $88,331 paid for services in 2024. Astrazeneca Pharmaceuticals LP reported $19.35 in payments in 2025, mostly food and beverage.

Overview

NPI1376527630
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedDec 1, 2005
Last updated in NPPESNov 16, 2010

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pulmonary Disease (MA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients815
Services billed2,090 across 29 procedure codes
Paid by Medicare$88,331

Part D prescriptions in 2024

Prescriptions (claims)4,296 · 5,936 30-day fills
Patients662
Total drug cost$2,295,722
Generic share32% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$19.35 · 1 payment from 1 company
  • 2024$78.82 · 4 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Astrazeneca Pharmaceuticals LP$19.351

What the 2025 payments were for

  • Food and Beverage$19.35 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Pulmonary Disease providers in Burlington

All Internal Medicine, Pulmonary Disease providers in Massachusetts →